山西医药杂志
山西醫藥雜誌
산서의약잡지
SHANXI MEDICAL JOURNAL
2014年
3期
258-260
,共3页
甘伙烨%彭铁立%赵琳丽%姚莉亚%苏凯华%梁凤玲
甘夥燁%彭鐵立%趙琳麗%姚莉亞%囌凱華%樑鳳玲
감화엽%팽철립%조림려%요리아%소개화%량봉령
螺杆菌 ,幽门%药物疗法%治疗结果
螺桿菌 ,幽門%藥物療法%治療結果
라간균 ,유문%약물요법%치료결과
Helicobacter pylori%Drug therapy%T reatment outcome
目的:比较标准三联疗法、四联疗法及序贯疗法根除幽门螺杆菌(H p )的疗效及安全性。方法300例非溃疡性消化不良者随机入选三联、四联及序贯疗法组,三联疗法组予兰索拉唑+阿莫西林+克拉霉素治疗10 d。四联疗法组予兰索拉唑+胶体次枸橼酸铋+阿莫西林+克拉霉素治疗10 d。序贯疗法组前5 d予兰索拉唑+阿莫西林治疗,后5 d予兰索拉唑+克拉霉素+甲硝唑治疗。治疗结束至少停药4周后复查14 C尿素呼气试验,结果阴性表示根除成功。同时评估疗效及安全性。对 Hp根除率进行意向性分析和符合方案分析比较。结果意向性分析显示三联疗法组、四联疗法组及序贯疗法组的 H p根除率分别是66%(66/100)、82%(82/100)及84%(84/100)。符合方案分析显示三联疗法组、四联疗法组及序贯疗法组的 H p根除率分别是72%(66/92)、91%(82/90)及89%(84/94)。意向性分析及符合方案分析均表明三联疗法组 H p根除率明显低于四联疗法组或序贯疗法组,差异有统计学意义(P均<0.05),而四联疗法组与序贯疗法组间差异无统计学意义(P>0.05)。结论四联疗法或序贯疗法可作为临床根治 Hp的一线治疗方案。
目的:比較標準三聯療法、四聯療法及序貫療法根除幽門螺桿菌(H p )的療效及安全性。方法300例非潰瘍性消化不良者隨機入選三聯、四聯及序貫療法組,三聯療法組予蘭索拉唑+阿莫西林+剋拉黴素治療10 d。四聯療法組予蘭索拉唑+膠體次枸櫞痠鉍+阿莫西林+剋拉黴素治療10 d。序貫療法組前5 d予蘭索拉唑+阿莫西林治療,後5 d予蘭索拉唑+剋拉黴素+甲硝唑治療。治療結束至少停藥4週後複查14 C尿素呼氣試驗,結果陰性錶示根除成功。同時評估療效及安全性。對 Hp根除率進行意嚮性分析和符閤方案分析比較。結果意嚮性分析顯示三聯療法組、四聯療法組及序貫療法組的 H p根除率分彆是66%(66/100)、82%(82/100)及84%(84/100)。符閤方案分析顯示三聯療法組、四聯療法組及序貫療法組的 H p根除率分彆是72%(66/92)、91%(82/90)及89%(84/94)。意嚮性分析及符閤方案分析均錶明三聯療法組 H p根除率明顯低于四聯療法組或序貫療法組,差異有統計學意義(P均<0.05),而四聯療法組與序貫療法組間差異無統計學意義(P>0.05)。結論四聯療法或序貫療法可作為臨床根治 Hp的一線治療方案。
목적:비교표준삼련요법、사련요법급서관요법근제유문라간균(H p )적료효급안전성。방법300례비궤양성소화불량자수궤입선삼련、사련급서관요법조,삼련요법조여란색랍서+아막서림+극랍매소치료10 d。사련요법조여란색랍서+효체차구연산필+아막서림+극랍매소치료10 d。서관요법조전5 d여란색랍서+아막서림치료,후5 d여란색랍서+극랍매소+갑초서치료。치료결속지소정약4주후복사14 C뇨소호기시험,결과음성표시근제성공。동시평고료효급안전성。대 Hp근제솔진행의향성분석화부합방안분석비교。결과의향성분석현시삼련요법조、사련요법조급서관요법조적 H p근제솔분별시66%(66/100)、82%(82/100)급84%(84/100)。부합방안분석현시삼련요법조、사련요법조급서관요법조적 H p근제솔분별시72%(66/92)、91%(82/90)급89%(84/94)。의향성분석급부합방안분석균표명삼련요법조 H p근제솔명현저우사련요법조혹서관요법조,차이유통계학의의(P균<0.05),이사련요법조여서관요법조간차이무통계학의의(P>0.05)。결론사련요법혹서관요법가작위림상근치 Hp적일선치료방안。
Objective To compare the efficacy and safety of triple therapy ,therapy ,quadruple therapy and sequential therapy in Helicobacter pylori (Hp) eradication .Methods A total of 300 Hp positive patients with non-ulcer dyspepsia were recruited and randomly assigned into triple therapy ,therapy ,quadruple therapy and se-quential therapy group .The patients in tripietriple therapy group received lansoprazole ,amoxicillin and clarithro-mycin forclarithromycin for 10 days .The patients in quadruple therapy group received lansoprazole ,colloidal bis-muth subcitrate ,amoxicillin and clarithromycin forclarithromycin for 10 days .The patients in sequential therapy group received lansoprazole with amoxicillin for 5 days ,and then lansoprazole with clarithromycin and metron-idazole for another five days .The 14C-urea breathe test was re-examined at least 4 weeks after the completion of treatment ,the result with Hp negative indicated the success of Hp eradication .The efficacy and safety were also evaluated .Hp eradication rates were compared with the intention-to-treat(ITT) and per protocol (PP) analysis . Results According to ITT analysis ,the eradication rates of Hp in triple therapy group ,quadruple therapy group , and sequential therapy group were 66% (66/100) ,82% (82/100) and 84% (84/100) respectively .According to PP analysis ,the eradication rates of Hp in triple therapy group ,quadruple therapy group ,and sequential therapy group were 72% (66/92) ,91% (82/90) and 89% (84/94) respectively .Whether with ITT analysis or with ITT analysis ,the Hp eradication rate in the triple therapy group was lower than that of the quadruple therapy group or that of the sequential therapy group .There was significant difference .However ,there was no significant differ-ence of the Hp eradication betweentbetween the quadruple therapy group and the sequential therapy group .Con-clusion The quadruple therapy and the sequential therapy should be considered as the first line choice .